Carna Biosciences, Inc. (TYO:4572)

Carna Biosciences Revenue

Carna Biosciences had revenue of 183.00M JPY in the quarter ending March 31, 2026, with 27.66% growth. This brings the company's revenue in the last twelve months to 618.65M, up 3.33% year-over-year. In the year 2025, Carna Biosciences had annual revenue of 579.00M, down -8.96%.

• Revenue (ttm): 618.65M
• Revenue Growth: +3.33%
• P/S Ratio: 13.02
• Revenue / Employee: 10.14M
• Employees: 61
• Market Cap: 8.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	579.00M	-57.00M	-8.96%
Dec 31, 2024	636.00M	-989.00M	-60.86%
Dec 31, 2023	1.63B	239.00M	17.24%
Dec 31, 2022	1.39B	-631.00M	-31.28%
Dec 31, 2021	2.02B	884.00M	78.02%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error